Latest News and Press Releases
Want to stay updated on the latest news?
-
PRESS RELEASE Algenex raises €7.4 million in financing round Madrid (Spain), September 8, 2020.- Algenex SL, a private biotechnology company delivering disruptive technologies for recombinant...
-
PRESS RELEASE Algenex and Global DX Announce Positive Evaluation of Herdscreen® ASFV Antibody Test for African Swine Fever Analysis of this new rapid test at the European Union Reference Laboratory...
-
PRESS RELEASE Algenex advances insect-based vaccine production technology in human health CrisBio® offers efficient, economic and rapid response tool in pandemics. Madrid, May 5, 2020.- Algenex SL...
-
PRESS RELEASE Algenex and FATRO sign commercial license agreement for development of a second CrisBio®-based vaccine Agreement strengthens collaboration between the companies...
-
PRESS RELEASE First Algenex CrisBio®-based vaccine submitted to European Medicines Agency Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of...
-
PRESS RELEASE Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever Madrid (Spain) and Stirling (UK), May 28, 2019 –...
-
PRESS RELEASE ALGENEX appoints new Strategic Advisory Board (SAB) Advisors include recognized industry leaders in international healthcare Madrid (Spain), March 13, 2019 – ALGENEX SL (the...
-
PRESS RELEASE ALGENEX closes funding round and strengthens team with key senior manager appointments Madrid (Spain), March 5, 2019 – ALGENEX SL (the “company”), a private biotechnology company...